CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-13 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −806 | $14.64 | $12K | 216,585 |
| 2025-08-12 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,937 | $13.58 | $40K | 217,391 |
| 2025-08-05 | Ho Carole Chief Medical Officer | Option exercise | +44,655 | $0.68 | $30K | 220,328 |
| 2025-08-05 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −44,655 | 62,500 | ||
| 2025-01-07 | Ho Carole Chief Medical Officer | Sale | −2,907 | $20.81 | $60K | 175,673 |
| 2025-01-06 | Ho Carole Chief Medical Officer | Sale | −12,255 | $20.22 | $248K | 178,580 |
| 2025-01-03 | Ho Carole Chief Medical Officer | Grant or award | +54,180 | 190,835 | ||
| 2025-01-03 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +162,540 | 162,540 | ||
| 2024-11-25 | Ho Carole Chief Medical Officer | Option exercise | +17,845 | $0.68 | $12K | 136,655 |
| 2024-11-25 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −17,845 | 107,155 | ||
| 2024-08-21 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −14,098 | $24.41 | $344K | 124,717 |
| 2024-08-21 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −5,907 | $24.96 | $147K | 118,810 |
| 2024-08-20 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,453 | $23.79 | $58K | 138,815 |
| 2024-08-13 | Ho Carole Chief Medical Officer | Sale | −2,337 | $22.89 | $53K | 141,268 |
| 2024-02-14 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −1,405 | $17.79 | $25K | 143,605 |
| 2024-02-13 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,784 | $17.29 | $48K | 145,010 |
| 2024-01-10 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −4,668 | $19.02 | $89K | 147,794 |
| 2024-01-05 | Ho Carole Chief Medical Officer | Sale | −9,972 | $19.43 | $194K | 198,777 |
| 2024-01-03 | Ho Carole Chief Medical Officer | Grant or award | +53,720 | 162,434 | ||
| 2024-01-03 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +161,160 | 161,160 |
Page 1 of 11 · 210 trades